CytoReason Launches AI Assistant for Drug Development
Tel Aviv's CytoReason launches LINA AI assistant for drug development at JP Morgan Healthcare Conference, speeding research with accurate, biology-grounded.
Live Breaking Updates
Search Results
Real-time breaking news coverage from Israel and the Middle East. Stay informed with the latest developments as they happen.
Israeli AI Firm CytoReason Expands Drug Discovery Partnership With France’s Sanofi
Israeli AI firm CytoReason expands drug discovery partnership with Sanofi in a new multi-year agreement valued up to $16 million, marking its fifth commercial.